Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124813372 | 12481337 | 2 | F | 2008 | 20160917 | 20160620 | 20160923 | EXP | US-BIOGEN-2010BI033734 | BIOGEN | 53.90 | YR | F | Y | 0.00000 | 20160923 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124813372 | 12481337 | 1 | PS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | POWDER FOR SOLUTION FOR INJECTION | /wk | |||||||
| 124813372 | 12481337 | 2 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | |||||||
| 124813372 | 12481337 | 3 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk | |||||||
| 124813372 | 12481337 | 4 | SS | AVONEX | INTERFERON BETA-1A | 1 | Intramuscular | 103628 | 30 | UG | SOLN FOR INJECT IN PRE-FILLED SYRINGE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124813372 | 12481337 | 1 | Relapsing-remitting multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124813372 | 12481337 | HO |
| 124813372 | 12481337 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124813372 | 12481337 | Arthropathy | |
| 124813372 | 12481337 | Asthenia | |
| 124813372 | 12481337 | Breast cancer metastatic | |
| 124813372 | 12481337 | Breast cancer recurrent | |
| 124813372 | 12481337 | Cardiomegaly | |
| 124813372 | 12481337 | Catheter site pain | |
| 124813372 | 12481337 | Cognitive disorder | |
| 124813372 | 12481337 | Dysphemia | |
| 124813372 | 12481337 | Fear | |
| 124813372 | 12481337 | Fibromyalgia | |
| 124813372 | 12481337 | Injection site irritation | |
| 124813372 | 12481337 | Interstitial lung disease | |
| 124813372 | 12481337 | Laceration | |
| 124813372 | 12481337 | Loss of control of legs | |
| 124813372 | 12481337 | Memory impairment | |
| 124813372 | 12481337 | Mouth swelling | |
| 124813372 | 12481337 | Muscular weakness | |
| 124813372 | 12481337 | Pain | |
| 124813372 | 12481337 | Pain in extremity | |
| 124813372 | 12481337 | Peripheral swelling | |
| 124813372 | 12481337 | Therapeutic response unexpected | |
| 124813372 | 12481337 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124813372 | 12481337 | 1 | 20040620 | 20070120 | 0 | |
| 124813372 | 12481337 | 2 | 20080219 | 0 | ||
| 124813372 | 12481337 | 3 | 20080326 | 20101011 | 0 | |
| 124813372 | 12481337 | 4 | 20150530 | 0 |